Quick Links
About MyKidneyCancerTeam
Powered By
Below is a listing of treatments and therapies for kidney cancer. Click on one to read more information or connect with others currently using it.
Overview
Afinitor is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults after failure of treatment with either sunitinib or sorafenib. It is used as…
Overview
Avastin is approved by the U.S. Food and Drug Administration (FDA) for use in treating metastatic renal cell carcinoma (a type of advanced kidney cancer) when given in combination with interferon alfa. This…
Overview
Bavencio is approved by the U.S. Food and Drug Administration (FDA) as a first-line treatment, in combination with axitinib, for adults with advanced renal cell carcinoma (RCC), a common type of kidney cancer…
Overview
Cabometyx is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma (RCC). It may be used either as a single agent or in combination with nivolumab…
Overview
Fotivda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma (RCC), a type of kidney cancer, after they have received…
Overview
Inlyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is used in combination with either avelumab or pembrolizumab…
Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults. It is used in combination with axitinib or lenvatinib as a first-line…
Overview
Lenvima is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma, a form of kidney cancer. It is prescribed in combination with pembrolizumab for adults as a…
Overview
Nexavar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is typically prescribed for individuals whose cancer is…
Overview
Opdivo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma, a common type of kidney cancer. It can be used as a first-line treatment in…
Overview
Sutent is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults. It is also approved as an adjuvant treatment (additional therapy after…
Overview
Torisel is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC). This therapy is typically used in cases where the cancer has spread and cannot be…
Overview
Votrient is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a form of kidney cancer. It is typically prescribed to adults whose cancer has spread…
Overview
Welireg is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma (RCC) with a clear cell component. To be eligible, a person must have previously…
Overview
Yervoy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults who are considered intermediate- or poor-risk. It is used as a first-line…
Sign up for free!
Join
Your privacy is our priority.